Skip to main content
Log in

Metastatic orbital tumors in southern China during an 18-year period

  • Oculoplastics and Orbit
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Objective

To determine the primary sites, clinical features, treatment, and outcome of 46 patients with cancer metastatic to the orbits in southern China.

Methods

Retrospective review of medical records at a tertiary center in southern China between Jan 1, 1991 and Dec 31, 2008.

Results

The study included 35 males and 11 females, with an age range of 3–78 years (average 47 years). All of the patients came from southern China. The left orbit was affected more frequently than the right orbit (3:2), and no cases were bilaterally involved. The most common primary cancer that metastasizes to the orbit is nasopharyngeal carcinoma (30.34%), followed by lung cancer (8.70%), liver cancer (6.52%), breast carcinoma (4.35%), renal cell cancer (4.35%), medullary thyroid carcinoma (2.17%), lacrimal gland carcinoma (2.17%), stomach carcinoma (2.17%), mediastinum carcinoma (2.17%), other forms (6.52%), and unknown carcinomas (30.34%). Orbital metastasis was the first sign of systemic cancer in 24 patients (52.17%). The five most common clinical findings at the initial examination were abnormal eye position (65.22%), proptosis (63.04%), increased orbital pressure (54.35%), diplopia (54.35%), and limited ocular motility (52.17%), followed by swollen eyelid (50%), visible mass or swelling (46%), blurred vision (41%), conjunctival hyperemia, and edema (35%), pain (28%), blepharoptosis (20%), papilledema (17%), and vasodilatation of the retina (7%). Primary treatment included surgical excision, radiotherapy, systemic chemotherapy, and observation. Among the patients (78% of 46) with sufficient follow-up time (mean 20.7 months), 30.56% of them died of disseminated metastasis. Twenty-five percent of them were in remission with no active metastases and 27.78% of them were living with active metastases. Overall, the mean survival time was 18 months (range, 5–38 months) after diagnosis of orbital metastasis.

Conclusions

The most common primary cancer that metastasizes to the orbit is nasopharyngeal carcinoma (30.34%), followed by lung cancer (8.70%) and liver cancer (6.52%) in southern China. Orbital metastasis can display a variety of clinical features and should be considered in patients with known systemic cancer. The systemic prognosis is generally poor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Shields JA, Shields CL, Scartozzi R (2004) Survey of 1,264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part 1. Ophthalmology 111:997–1008

    Article  PubMed  Google Scholar 

  2. Garrity JA, Henderson JW, Cameron JD (2007) Metastatic carcinomas. In: Henderson’s orbital tumors, 4th edn. Raven Press, New York, pp 313–326

  3. Seregard S, Sahlin S (1999) Panorama of orbital space-occupying lesions: the 24-year experience of a referral centre. Acta Ophthalmol Scand 77:91–98

    Article  PubMed  CAS  Google Scholar 

  4. Shields JA, Shields CL (1999) Metastatic tumors to the orbit. In: Shields JA, Shields CL (eds) Atlas of orbital tumors. Lippincott Williams & Wilkins, Philadelphia, pp 187–197

    Google Scholar 

  5. Bloch RS, Gartner S (1971) The incidence of ocular metastatic carcinoma. Arch Ophthalmol 85:673–675

    PubMed  CAS  Google Scholar 

  6. Henderson JW, Campbell RJ, Farro GM (1994) Orbital tumors, 3rd edn. Raven Press, New York, pp 361–376

    Google Scholar 

  7. Shields JA, Shields CL, Brotman HK, Carvalho C, Perez N, Eagle RC Jr (2001) Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture. Ophthalmic Plastic Reconstr Surg 17:346–354

    Article  CAS  Google Scholar 

  8. Goldberg RA, Rootman J (1990) Clinical characteristics of metastatic orbital tumors. Ophthalmology 97:620–624

    PubMed  CAS  Google Scholar 

  9. Font RL, Ferry AP (1976) Carcinoma metastatic to the eye and orbit III. A clinicopathologic study of 28 cases metastatic to the orbit. Cancer 38:1326–1335

    Article  PubMed  CAS  Google Scholar 

  10. Gunlp I, Gunduz K (1995) Metastatic orbital tumors. Jpn J Ophthalmol 39:65–70

    Google Scholar 

  11. Boldt HC, Nerad JA (1988) Orbital metastases from prostate carcinoma. Arch Ophthalmol 106:1403–1408

    PubMed  CAS  Google Scholar 

  12. Valenzuela AA, Archibald CW, Fleming B, Ong L, O'Donnell B, Crompton JJ, Selva D, McNab AA, Sullivan TJ (2009) Orbital metastasis: clinical features, management and outcome. Orbit 28:153–159

    Article  PubMed  Google Scholar 

  13. Chew CT (1987) Nasopharynx (the postnasal space). In: Kerr AG, MacKay IS, Bull TR (eds) Scott-Brown's otolaryngology, 5th edn. London, Butterworths

    Google Scholar 

  14. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents, vol 7. IARC, Lyon, pp 334–337

    Google Scholar 

  15. Lee KYC, Seah LL, Tow S, Cullen JF, Fong KS (2008) Nasopharyngeal carcinoma with orbital involvement. Ophthalmic Plast Reconstr Surg 24:185–189

    Article  Google Scholar 

  16. Shields JA (1989) Diagnosis and management of orbital tumors. Philadelphia: Sanders. pp 89-122

  17. Ahmad SM, Esmaeli B (2007) Metastatic tumors of the orbit and ocular adnexa. Curr Opin Ophthalmol 18:405–413

    Article  PubMed  Google Scholar 

  18. Wang SS, Lu RH, Lee FY, Chao Y, Huang YS, Chen CC, Lee SD (1996) Utility of lentil lectin affinity of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. J Hepatol 25:166–171

    Article  PubMed  CAS  Google Scholar 

  19. Strenger V, Kerbl R, Dornbusch HJ, Ladenstein R, Ambros PF, Ambros IM, Urban C (2007) Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients. Pediatr Blood Cancer 48:504–509

    Article  PubMed  Google Scholar 

  20. Potosky AL, Miller BA, Albertsen PC, Kramer BS (1995) The role of increasing detection in the rising incidence of prostate cancer. JAMA 273:548–552

    Article  PubMed  CAS  Google Scholar 

  21. James B (1982) The carcinoid syndrome. Cecil Textbook of Medicine, 16th edn. W.B. Saunder Co, Philadelphia, pp 1312–1314

    Google Scholar 

  22. Mesic JB, Fletcher GH, Goepfert H (1981) Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 7:447–453

    Article  PubMed  CAS  Google Scholar 

  23. Spano JP, Busson P, Atlan D, Bourhis J, Pignon JP, Esteban C, Armand JP (2003) Nasopharyngeal carcinomas: an update. Eur J Cancer 39:2121–2135

    Article  PubMed  Google Scholar 

  24. Teo PM, Chan AT, Lee WY, Leung TW, Johnson PJ (1999) Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. Int J Radiat Oncol Biol Phys 43:261–271

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jianhua Yan.

Additional information

The footnotes regarding sponsoring organizations

The paper was sponsored by the Natural Science Foundation of Guangdong Province, China (036651)

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 28 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yan, J., Gao, S. Metastatic orbital tumors in southern China during an 18-year period. Graefes Arch Clin Exp Ophthalmol 249, 1387–1393 (2011). https://doi.org/10.1007/s00417-011-1660-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-011-1660-6

Keywords

Navigation